Goldman Sachs’s scPharmaceuticals SCPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Sell |
101,888
-19,009
| -16% | -$72.4K | ﹤0.01% | 4402 |
|
|
2025
Q1 | $318K | Sell |
120,897
-288,563
| -70% | -$759K | ﹤0.01% | 4476 |
|
|
2024
Q4 | $1.45M | Buy |
409,460
+334,691
| +448% | +$1.18M | ﹤0.01% | 3694 |
|
|
2024
Q3 | $341K | Buy |
74,769
+40,298
| +117% | +$184K | ﹤0.01% | 4289 |
|
|
2024
Q2 | $150K | Buy |
34,471
+6,122
| +22% | +$26.6K | ﹤0.01% | 4434 |
|
|
2024
Q1 | $142K | Sell |
28,349
-16,847
| -37% | -$84.6K | ﹤0.01% | 4407 |
|
|
2023
Q4 | $283K | Buy |
45,196
+24,302
| +116% | +$152K | ﹤0.01% | 4213 |
|
|
2023
Q3 | $149K | Buy |
+20,894
| New | +$149K | ﹤0.01% | 4316 |
|
|
2023
Q2 | – | Sell |
-109,132
| Closed | -$990K | – | 5118 |
|
|
2023
Q1 | $990K | Buy |
109,132
+82,777
| +314% | +$751K | ﹤0.01% | 3663 |
|
|
2022
Q4 | $189K | Buy |
+26,355
| New | +$189K | ﹤0.01% | 4520 |
|
|
2021
Q3 | – | Sell |
-115,264
| Closed | -$704K | – | 5511 |
|
|
2021
Q2 | $704K | Sell |
115,264
-533,506
| -82% | -$3.26M | ﹤0.01% | 4239 |
|
|
2021
Q1 | $4.31M | Buy |
648,770
+609,002
| +1,531% | +$4.05M | ﹤0.01% | 2777 |
|
|
2020
Q4 | $210K | Buy |
39,768
+4,274
| +12% | +$22.6K | ﹤0.01% | 4251 |
|
|
2020
Q3 | $264K | Buy |
35,494
+16,482
| +87% | +$123K | ﹤0.01% | 3957 |
|
|
2020
Q2 | $140K | Buy |
19,012
+1,864
| +11% | +$13.7K | ﹤0.01% | 4090 |
|
|
2020
Q1 | $127K | Buy |
+17,148
| New | +$127K | ﹤0.01% | 4111 |
|
|
2018
Q4 | – | Sell |
-10,737
| Closed | -$63K | – | 4222 |
|
|
2018
Q3 | $63K | Sell |
10,737
-29,550
| -73% | -$173K | ﹤0.01% | 4007 |
|
|
2018
Q2 | $228K | Buy |
40,287
+9,201
| +30% | +$52.1K | ﹤0.01% | 3836 |
|
|
2018
Q1 | $385K | Sell |
31,086
-22,946
| -42% | -$284K | ﹤0.01% | 3602 |
|
|
2017
Q4 | $653K | Buy |
+54,032
| New | +$653K | ﹤0.01% | 3327 |
|